6039 Japan Animal Referral Medical Center Co.,Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

6039

TSE Growth

Japan Animal Referral Medical Center Co.,Ltd.

2,669

JPY

+37

(+1.41%)

May 7, 3:30 pm JST

18.67

USD

May 7, 2:30 am EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	2,847	405	410	285	120.7	0	May 6, 2021	J-GAAP
Mar, 2022	2,979	439	438	286	121.0	0	May 12, 2022	J-GAAP
Mar, 2023	3,872	580	534	380	156.3	0	May 11, 2023	J-GAAP
Mar, 2024	4,270	496	489	337	123.0	20	May 9, 2024	J-GAAP
Mar, 2025 Guidance	5,220	680	680	475	183.8	37	Feb 14, 2025	J-GAAP
YoY	+22.2%	+37.1%	+39.1%	+40.9%	+49.4%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 9, 2019	2,650	410	410	300	0	J-GAAP
Results	May 7, 2020	2,734	430	450	312	0	J-GAAP
Mar, 2021	May 7, 2020	Available in future release
Results	May 6, 2021
Mar, 2022	May 6, 2021
Results	May 12, 2022
Mar, 2023	May 12, 2022
Results	May 11, 2023
Mar, 2024	May 11, 2023
Results	May 9, 2024
Mar, 2025	May 9, 2024	4,820	625	625	440	25	J-GAAP
	Feb 14, 2025	5,220	680	680	475	37	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2010	878	－	Available in future release
Mar, 2011	1,040	+18.5
Mar, 2012	1,207	+16.1
Mar, 2013	1,327	+9.9
Mar, 2014	1,481	+11.6
Mar, 2015	1,894	+27.9
Mar, 2016	2,093	+10.5
Mar, 2017	2,191	+4.7
Mar, 2018	2,258	+3.1
Mar, 2019	2,563	+13.5
Mar, 2020	2,734	+6.7
Mar, 2021	2,847	+4.1
Mar, 2022	2,979	+4.6
Mar, 2023	3,872	+30.0
Mar, 2024	4,270	+10.3
Mar, 2025 Guidance	5,220	+22.2	680	+37.1	680	+39.1	183.8	+49.4

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	3,872	580	15.0	12.23	4.85	0.49	156.3
Mar, 2024	4,270	496	11.6	8.97	3.89	0.49	123.0
Mar, 2025 Guidance	5,220	680	13.0	11.77	5.51	0.61	183.8

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	4,270	580	534	380	4,168.0
Fiscal Year	Mar, 2024	Mar, 2023	Mar, 2023	Mar, 2023	Mar, 2014

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	1,542	257	252	159	67.2	0	May 12, 2022	J-GAAP
Oct - Mar, 2022	1,957	287	239	183	75.3	0	May 11, 2023	J-GAAP
Oct - Mar, 2023	2,288	337	337	240	87.6	20	May 9, 2024	J-GAAP
Oct - Mar, 2024 Guidance	2,651	330	329	233	90.1	37	Feb 14, 2025	J-GAAP
YoY	+15.9%	-2.1%	-2.4%	-2.9%	+2.9%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	439	-868	557	-1,425	722	968	13.62	J-GAAP
Mar, 2023	580	26	810	-784	820	1,816	21.17	J-GAAP
Mar, 2024	496	-86	899	-985	-392	1,337	15.25	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	2,915	456	421	279	119.8	78.8	Feb 9, 2023	J-GAAP
Apr - Dec, 2023	3,115	345	335	220	80.2	68.5	Feb 8, 2024	J-GAAP
Apr - Dec, 2024	3,942	590	590	409	157.9	86.8	Feb 14, 2025	J-GAAP
YoY	+26.5%	+71.0%	+76.1%	+85.9%	+96.8%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2023	957	124	113	101	41.6	13.0	May 11, 2023	J-GAAP
Apr - Jun, 2023	951	37	33	18	6.6	3.9	Aug 3, 2023	J-GAAP
Jul - Sep, 2023	1,031	122	119	79	29.0	11.8	Nov 9, 2023	J-GAAP
Oct - Dec, 2023	1,133	186	183	123	44.8	16.4	Feb 8, 2024	J-GAAP
Jan - Mar, 2024	1,155	151	154	117	42.7	13.1	May 9, 2024	J-GAAP
Apr - Jun, 2024	1,250	149	150	103	39.4	11.9	Aug 1, 2024	J-GAAP
Jul - Sep, 2024	1,319	201	201	139	53.7	15.2	Nov 7, 2024	J-GAAP
Oct - Dec, 2024	1,373	240	239	167	64.5	17.5	Feb 14, 2025	J-GAAP
YoY	+21.2%	+29.0%	+30.6%	+35.8%	+43.8%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2020	686	+7.4	Available in future release
Apr - Jun, 2020	699	+4.5
Jul - Sep, 2020	711	+3.2
Oct - Dec, 2020	721	+4.5
Jan - Mar, 2021	716	+4.4
Apr - Jun, 2021	719	+2.9
Jul - Sep, 2021	718	+1.0
Oct - Dec, 2021	793	+10.0
Jan - Mar, 2022	749	+4.6
Apr - Jun, 2022	934	+29.9
Jul - Sep, 2022	981	+36.6
Oct - Dec, 2022	1,000	+26.1
Jan - Mar, 2023	957	+27.8
Apr - Jun, 2023	951	+1.8
Jul - Sep, 2023	1,031	+5.1
Oct - Dec, 2023	1,133	+13.3
Jan - Mar, 2024	1,155	+20.7
Apr - Jun, 2024	1,250	+31.4
Jul - Sep, 2024	1,319	+27.9
Oct - Dec, 2024	1,373	+21.2	240	+29.0	239	+30.6	64.5	+44.0

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,373	240	239	167	64.5
Fiscal Year	Dec, 2024	Dec, 2024	Dec, 2024	Dec, 2024	Dec, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	1,078.80	35.3	7,107	2,509	1,994	1.56	May 12, 2022	J-GAAP
Mar, 2023	1,354.99	43.2	8,578	3,706	2,375	1.07	May 11, 2023	J-GAAP
Mar, 2024	1,446.52	43.5	8,770	3,811	2,712	1.01	May 9, 2024	J-GAAP
Apr - Dec, 2024	ー	46.8	8,628	4,036	3,068	0.90	Feb 14, 2025	J-GAAP

Japan Animal Referral Medical Center Co.,Ltd.(6039) Financial Results